Showing results (341-350 of 606) with videos related to

Sort By:
Pageof 61
Pharmacoeconomics - Open|February 10, 2023
The Evaluation of Drug Innovativeness in Italy: Key Determinants and Internal ConsistencyClaudio Jommi, Carlotta Galeone
Pharmacoeconomics - Open|January 7, 2021
Understanding Patients' Willingness to Pay for Biphasic Insulin Aspart 30/70 in a Pen Device for Type 2 Diabetes Treatment in an Out-of-Pocket Payment MarketSreenivasa Murthy, Pankaj Aneja, Arthur Joseph Asirvatham, et al.
Pharmacoeconomics - Open|July 2, 2021
The Utility of Economic Measures to Quantify the Burden of Tinnitus in Affected Individuals: A Scoping ReviewElza Daoud, Charlotte Caimino, Michael A Akeroyd, et al.
Pharmacoeconomics - Open|July 5, 2021
A Model-Based Economic Evaluation of Cladribine Versus Alemtuzumab, Ocrelizumab and Natalizumab for the Treatment of Relapsing-Remitting Multiple Sclerosis with High Disease Activity in ChileManuel Antonio Espinoza, Rubén Rojas, Alessandro Zaupa, et al.
Pharmacoeconomics - Open|July 13, 2021
The Costs and Healthcare Resource Utilization Associated with Anticholinergic Burden in Long-Stay Nursing Home Residents with Overactive Bladder in the USSatabdi Chatterjee, David Walker, Tomomi Kimura, et al.
Pharmacoeconomics - Open|April 27, 2023
Humanistic and Economic Burden of IgA Nephropathy: Systematic Literature Reviews and Narrative SynthesisKenar D Jhaveri, Mark E Bensink, Martin Bunke, et al.
Pharmacoeconomics - Open|June 29, 2019
Symptoms and Dietary Impact in Hypertriglyceridemia-Associated Pancreatitis: Development and Content Validity of Two New MeasuresClaire Burbridge, Jason A Randall, Robert J Sanchez, et al.
Pharmacoeconomics - Open|October 18, 2019
Ticagrelor Removal by CytoSorb® in Patients Requiring Emergent or Urgent Cardiac Surgery: A UK-Based Cost-Utility AnalysisMehdi Javanbakht, Miranda Trevor, Mohsen Rezaei Hemami, et al.
Pharmacoeconomics - Open|June 30, 2019
US Integrated Delivery Networks Perspective on Economic Burden of Patients with Treatment-Resistant Depression: A Retrospective Matched-Cohort StudyDominic Pilon, Holly Szukis, Kruti Joshi, et al.
Pharmacoeconomics - Open|October 17, 2019
Benefit-Cost Analysis of the Danish Sun Safety Campaign 2007-2015: Cost Savings from Sunburn and Sunbed Use Reduction and Derived Skin Cancer Reductions 2007-2040 in the Danish PopulationBrian Køster, Maria K H Meyer, Jes Søgaard, et al.
Pageof 61